Institutional members access full text with Ovid®

Share this article on:

Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease

Fischer, Aryeh MD, FACR*†‡§; Brown, Kevin K. MD, FCCP*†§; Frankel, Stephen K. MD, FCCP*†§

Clinical Pulmonary Medicine: March 2009 - Volume 16 - Issue 2 - pp 74-80
doi: 10.1097/CPM.0b013e31819b5400
Review Article

Interstitial lung disease is a common manifestation of connective tissue disease, and connective tissue disease-associated interstitial lung disease (CTD-ILD) is associated with significant morbidity and mortality. The treatment of CTD-ILD is often complex and challenging. This review focuses on the management of CTD-ILD.

Interstitial lung disease is a common pulmonary manifestation of the connective tissue diseases and is associated with significant morbidity and mortality. Connective tissue disease-associated interstitial lung diseases are also among the most difficult to treat. This review focuses up the management of connective tissue disease-associated interstitial lung disease.

From the *Autoimmune Lung Disease Center, †Interstitial Lung Disease Program, ‡Division of Rheumatology, National Jewish Medical and Research Center, and §Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver and Health Sciences Center, Denver, CO.

Address correspondence to: Stephen K. Frankel, MD, FCCP, National Jewish Medical and Research Center, G-012, 1400 Jackson St, Denver, CO 80206. E-mail: frankels@njc.org.

© 2009 Lippincott Williams & Wilkins, Inc.